Trial Profile
A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 70 and 50 and Fast-Acting Human Insulin in Patients With Type 1 Diabetes, A Randomised, Quadruple Crossover Trial.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin aspart/insulin protamine aspart (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Registrational; Therapeutic Use
- 07 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jul 2010 Actual end date (Jun 2010) added as reported by ClinicalTrials.gov.
- 04 Jun 2010 Planned end date changed from 1 Feb 2010 to 1 Aug 2010 as reported by ClinicalTrials.gov.